Anelis Quintana Cantillo, MSc, holds a bachelor’s degree in biology and a master’s degree in drug technology and control, both from Havana University. Anelis currently works in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana. Anelis has expertise in mammalian cell culture and fermentation processes development, laboratory-scale purification of monoclonal antibodies, and quantification and analytical characterization of monoclonal antibodies by ELISA, weak cation exchange chromatography and gel filtration in HPLC, SDS-PAGE, western blot, etc.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1
and chronic conditions such as cancer
1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061